☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Prevention
Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment
June 24, 2021
Nutraceuticals Under Evaluation for COVID-19 Prevention and Treatment
June 24, 2021
AstraZeneca's AZD7442 Fails to Meet its Primary Endpoint in P-III STORM CHASER Study for the Prevention of Symptomatic COVID-19
June 15, 2021
AstraZeneca's AZD7442 Fails to Meet its Primary Endpoint in P-III STORM CHASER Study for the Prevention of Symptomatic COVID-19
June 15, 2021
Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue
March 26, 2021
Takeda Reports EMA's Acceptance of TAK-003 for the Prevention of Dengue
March 26, 2021
Load more...
Back to Home